BREAKING🔔 A new study from G2P-Japan🇯🇵 is out at bioRxiv @biorxivpreprint. We elucidated the virological characteristics of SARS-CoV-2 JN.1 - a progeny of BA.2.86 (#Pirola). Please RT🔥 1/ biorxiv.org/content/10.110…
Cf. This is JN.1 (aka BA.2.86.1.1; in spike, JN.1 = BA.2.86 + S:L455S. Importantly, we remember that the L455 substitution, S:L455F, was observed in the XBB lineage (e.g., HK.3 and these are known as "FLip" subvariants). 2/
Transmissibility/fitness (Re):
Molecular phylogenetic-epidemic dynamics modeling led by Jumpei @jampei2 and Kaho showed that the Re of JN.1 is apparently greater than that of BA.2.86 and others, suggesting that S:L455S can contribute to the increased fitness of JN.1. 3/
ACE2 binding & pseudovirus infectivity:
ACE2 binding: BA.2.86 < JN.1
Pseudovirus infectivity: BA.2.86 > JN.1
Effect of S:L455S is different between monomeric RBD and trimerized whole S protein🤔? 4/
Immune resistance (rodent sera):
In cases of BA.2.86-infected hamster sera and BA.2.86 S-immunizesd mouse sera, the 50% neutralization titer (NT50) between BA.2.86 and JN.1 was comparable, suggesting that S:L455S does not affect the antigenicity of BA.2.86. 5/
Immune resistance (human sera):
On the other hand, the NT50 of breakthrough infection (BTI) sera with XBB.1.5 and EG.5.1 against JN.1 was significantly lower than that of HK.3 (2.6- to 3.1-fold) and BA.2.86 (3.8-fold)🔥 6/
Furthermore, JN.1 shows a robust resistance to monovalent XBB.1.5 vaccine sera🔥 These results suggest that JN.1 is one of the most immune-evading variants to date. S:L455S can contribute to increased immune evasion, which partly explains the increased Re of JN.1. 7/7
• • •
Missing some Tweet in this thread? You can try to
force a refresh
BREAKING🔔 A new study from G2P-Japan🇯🇵 is out! The preprint will be out so soon, but we first show our results on the efficacy of XBB.1.5 monovalent vaccine - comparison between infection-naïve and XBB-infected individuals. Please retweet/repost🔥 1/
XBB.1.5 monovalent mRNA vaccine has been available since September 2023. However, we found that breakthrough infection with XBB subvariants, including XBB.1.5, does not efficiently induce humoral immunity against the infecting XBB subvariants. e.g., 2/
These observations raise the possibility that the XBB.1.5 monovalent vaccine may not be able to efficiently induce humoral immunity against emerging SARS-CoV-2 variants, including a variety of XBB subvariants as well as BA.2.86. 3/
BREAKING🔔 A new study from G2P-Japan🇯🇵 is out at bioRxiv @biorxivpreprint. We elucidated the virological characteristics of SARS-CoV-2 BA.2.86 (aka #Pirola).
*BA.2.86 is has >30 mutations in the genome.
Please RT🔥 1/ biorxiv.org/content/10.110…
Epidemic dynamics modeling by @jampei2 and @JarelElgin showed that the relative effective reproduction number (Re) of BA.2.86 is 1.07-fold higher than that of the currently predominant EG.5.1, suggesting that BA.2.86 has the potential to become the next predominant one. 2/
Growth assay showed that the replication capacity of BA.2.86 is similar to or lower than that of BA.2, its parental strain. BA.2.86 is less replicative than EG.5.1 at the cell culture level. 3/
BREAKING🔔 The 28th paper from G2P-Japan🇯🇵 is out at Lancet Infectious Diseases @TheLancetInfDis. We elucidated the virological characteristics of new SARS-CoV-2 variant under monitoring, BA.2.86 (aka #Pirola). Please retweet/repost🔥 1/ thelancet.com/journals/lanin…
Here I summarized the mutations detected in BA.2.86. 2/
1⃣Transmissibility/fitness (Re):
Analysis by Jumpei @jampei2 using the data from 🇩🇰 showed that BA.2.86's Re is greater than XBB.1.5 and comparable to or even greater than EG.5.1. 3/
BREAKING🔔 The 27th paper from G2P-Japan🇯🇵 is out at Lancet Infectious Diseases @TheLancetInfDis. We elucidated the virological characteristics of new SARS-CoV-2 variant of interest, EG.5 (aka #Eris) Please RT🔥 1/ thelancet.com/journals/lanin…
Currently, a subvariant of XBB.1.9, EG.5 (aka XBB.1.9.2.5) is well documented in Twitter (maybe aka #X) and elsewhere. 2/
* EG.5.1 S = XBB.1.9.2 S + #Q52H + #F456L
* XBB.1.9.2 S = XBB.1.5 S.